The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
6 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $719,264 in first-year total cost, median $119,344.
Most frequent study sections
- Special Emphasis Panel[ZNS1 SRB-D (03)]6
Most frequent institutions
- AUGUSTA UNIVERSITY1
- JOHNS HOPKINS UNIVERSITY1
- MASSACHUSETTS GENERAL HOSPITAL1
- UNIVERSITY OF IOWA1
- UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | Yale site for Stroke Preclinical Assessment Network (SPAN) for Acute Neuroprotection1U01NS113445-01 | SANSING, LAUREN H | YALE UNIVERSITY, CT | $125,625 | ZNS1 |
| 2019 | Multicenter preclinical trial of rho-kinase inhibitor fasudil in acute focal cerebral ischemia and reperfusion1U01NS113443-01 | AYATA, CENK | MASSACHUSETTS GENERAL HOSPITAL, MA | $125,093 | ZNS1 |
| 2019 | Preclinical stroke trial with the PARP inhibitor veliparib1U01NS113444-01 | KOEHLER, RAYMOND CHARLES | JOHNS HOPKINS UNIVERSITY, MD | $122,813 | ZNS1 |
| 2019 | The University of Iowa Stroke Preclinical Assessment Center for Neuroprotection in stroke1U01NS113388-01 | CHAUHAN, ANIL KUMARLEIRA, ENRIQUE CARLOS | UNIVERSITY OF IOWA, IA | $115,875 | ZNS1 |
| 2019 | Stroke Preclinical Assessment Network (SPAN) – Tacilizumab for treatment of acute ischemic stroke1U01NS113451-01 | ARONOWSKI, JAROSLAW | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX | $115,389 | ZNS1 |
| 2019 | Remote Ischemic Conditioning: A collateral therapeutic and neuroprotectant1U01NS113356-01 | HESS, DAVID C. | AUGUSTA UNIVERSITY, GA | $114,469 | ZNS1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.